Structure–activity relationship of a peptide permeation enhancer

References

• Alqahtani S. In silico ADME-Tox modeling: progress and prospects. Expert Opin Drug Metab Toxicol. 2017;13(11):1–12. doi:10.1080/17425255.2017.1389897.
   PubMed Web of Science ®Google Scholar
• Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharm. 2012;2012:1–10. doi:10.5402/2012/195727.
   Google Scholar
• Lemmer HJ, Hamman JH. Paracellular drug absorption enhancement through tight junction modulation. Expert Opin Drug Deliv. 2013;10(1):103–114. doi:10.1517/17425247.2013.745509.
   PubMed Web of Science ®Google Scholar
• Van Itallie CM, Holmes J, Bridges A, Gookin JL, Coccaro MR, Proctor W, Colegio OR, Anderson JM. The density of small tight junction pores varies among cell types and is increased by expression of claudin-2. J Cell Sci. 2008;121(3):298–305. doi:10.1242/jcs.021485.
   PubMed Web of Science ®Google Scholar
• Van Itallie CM, Anderson JM. Architecture of tight junctions and principles of molecular composition. Semin Cell Dev Biol. 2014;36:157–165. doi:10.1016/j.semcdb.2014.08.011.
   PubMed Web of Science ®Google Scholar
• Luo X, Guo L, Zhang J, Xu Y, Gu W, Feng L, Wang Y. Tight junction protein occludin is a porcine epidemic diarrhea virus entry factor. J Virol. 2017;91(10). doi:10.1128/JVI.00202-17.
   Web of Science ®Google Scholar
• Skamrahl M, Pang H, Ferle M, Gottwald J, Rübeling A, Maraspini R, Honigmann A, Oswald TA, Janshoff A. Tight junction ZO proteins maintain tissue fluidity. Ensuring Efficient Collective Cell Migration, Adv Sci. 2021:2100478. doi:10.1002/advs.202100478.
   Google Scholar
• Günzel D, Yu ASL. Claudins and the modulation of tight junction permeability. Physiol Rev. 2013;93(2):525–569. doi:10.1152/physrev.00019.2012.
   PubMed Web of Science ®Google Scholar
• Kaminsky LW, Al-Sadi R, Ma TY. IL-1β and the intestinal epithelial tight junction barrier. Front Immunol. 2021;12:767456. doi:10.3389/fimmu.2021.767456.
   PubMed Web of Science ®Google Scholar
• Al-Sadi R. Mechanism of cytokine modulation of epithelial tight junction barrier. Front Biosci. 2009:2765. doi:10.2741/3413.
   Google Scholar
• Shin K, Fogg VC, Margolis B. Tight Junctions and Cell Polarity, Annu. Rev Cell Dev Biol. 2006;22(1):207–235. doi:10.1146/annurev.cellbio.22.010305.104219.
   PubMedGoogle Scholar
• O’Leary LF, Tomko AM, Dupré DJ. Polarity scaffolds signaling in epithelial cell permeability. Inflamm Res. 2021;70(5):525–538. doi:10.1007/s00011-021-01454-1.
   PubMed Web of Science ®Google Scholar
• Leonardo TR, Shi J, Chen D, Trivedi HM, Chen L. Differential expression and function of bicellular tight junctions in skin and oral wound healing. IJMS. 2020;21(8):2966. doi:10.3390/ijms21082966.
   Google Scholar
• Stuart RO, Nigam SK. Regulated assembly of tight junctions by protein kinase C. Proc Nat Acad Sci. 1995;92: 6072–6076. doi: 10.1073/pnas.92.13.6072.
   PubMed Web of Science ®Google Scholar
• Ogasawara N, Kojima T, Go M, Ohkuni T, Koizumi J, Kamekura R, Masaki T, Murata M, Tanaka S, Fuchimoto J, et al. PPARγ agonists upregulate the barrier function of tight junctions via a PKC pathway in human nasal epithelial cells. Pharmacol Res. 2010;61(6):489–498. doi:10.1016/j.phrs.2010.03.002.
   PubMed Web of Science ®Google Scholar
• Brunner J, Ragupathy S, Borchard G. Target specific tight junction modulators. Adv Drug Deliv Rev. 2021;171:266–288. doi:10.1016/j.addr.2021.02.008.
   PubMed Web of Science ®Google Scholar
• Twarog C, Fattah S, Heade J, Maher S, Fattal E, Brayden DJ. Intestinal permeation enhancers for oral delivery of macromolecules: a comparison between salcaprozate sodium (SNAC) and sodium caprate (C10. Pharmaceutics. 2019;11(2):78. doi:10.3390/pharmaceutics11020078.
   PubMed Web of Science ®Google Scholar
• Liang W, Xu W, Zhu J, Zhu Y, Gu Q, Li Y, Guo C, Huang Y, Yu J, Wang W, et al. Ginkgo biloba extract improves brain uptake of ginsenosides by increasing blood-brain barrier permeability via activating A1 adenosine receptor signaling pathway. J Ethnopharmacol. 2020;246:112243. doi:10.1016/j.jep.2019.112243.
   PubMed Web of Science ®Google Scholar
• Shiobara T, Usui T, Han J, Isoda H, Nagumo Y. The reversible increase in tight junction permeability induced by capsaicin is mediated via cofilin-actin cytoskeletal dynamics and decreased level of occludin. PLoS ONE. 2013;8(11):e79954. doi:10.1371/journal.pone.0079954.
   PubMed Web of Science ®Google Scholar
• Danielsen EM, Hansen GH. Probing paracellular -versus transcellular tissue barrier permeability using a gut mucosal explant culture system. Tissue Barriers. 2019;7(1):1601955. doi:10.1080/21688370.2019.1601955.
   PubMed Web of Science ®Google Scholar
• Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology. 2004;127(1):224–238. doi:10.1053/j.gastro.2004.04.015.
   PubMed Web of Science ®Google Scholar
• Li Z, Liu X, Liu Y, Xue Y, Wang P, Liu L, Liu J, Yao Y, Ma J. Roles of serine/threonine phosphatases in low-dose endothelial monocyte-activating polypeptide-II-induced opening of blood–tumor barrier. J Mol Neurosci. 2015;57(1):11–20. doi:10.1007/s12031-015-0604-8.
   PubMed Web of Science ®Google Scholar
• Hug H, Sarre TF. Protein kinase C isoenzymes: divergence in signal transduction? Biochem J. 1993;291(2):329–343. doi:10.1042/bj2910329.
   PubMedGoogle Scholar
• Goldstein B, Macara IG. The PAR proteins: fundamental players in animal cell polarization. Dev Cell. 2007;13(5):609–622. doi:10.1016/j.devcel.2007.10.007.
   PubMed Web of Science ®Google Scholar
• Sakane F, Hoshino F, Ebina M, Sakai H, Takahashi D. The roles of diacylglycerol kinase α in cancer cell proliferation and apoptosis. Cancers. 2021;13(20):5190. doi:10.3390/cancers13205190.
   PubMed Web of Science ®Google Scholar
• Nusrat A, Turner JR, Madara JL. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol. 2000;279(5):G851–857. doi:10.1152/ajpgi.2000.279.5.G851.
   PubMed Web of Science ®Google Scholar
• Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA, Messing RO. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol. 2000;279(3):L429–L438. doi:10.1152/ajplung.2000.279.3.L429.
   PubMed Web of Science ®Google Scholar
• Sadeghi MM, Salama MF, Hannun YA. Protein kinase C as a therapeutic target in non-small cell lung cancer. IJMS. 2021;22(11):5527. doi:10.3390/ijms22115527.
   Google Scholar
• Apostolatos A, Song S, Acosta S, Peart M, Watson JE, Bickford P, Cooper DR, Patel NA. Insulin promotes neuronal survival via the alternatively spliced protein kinase CδII isoform. J Biol Chem. 2012;287(12):9299–9310. doi:10.1074/jbc.M111.313080.
   PubMed Web of Science ®Google Scholar
• Fields AP, Murray NR. Protein kinase C isozymes as therapeutic targets for treatment of human cancers. Adv Enzyme Regul. 2008;48(1):166–178. doi:10.1016/j.advenzreg.2007.11.014.
   PubMedGoogle Scholar
• Ratnayake WS, Apostolatos CA, Breedy S, Dennison CL, Hill R, Acevedo-Duncan M. Atypical PKCs activate Vimentin to facilitate prostate cancer cell motility and invasion. Cell Adh Migr. 2021;15(1):37–57. doi:10.1080/19336918.2021.1882782.
   PubMed Web of Science ®Google Scholar
• Manda B, Mir H, Gangwar R, Meena AS, Amin S, Shukla PK, Dalal K, Suzuki T, Rao RK. Phosphorylation hotspot in the C-terminal domain of occludin regulates the dynamics of epithelial junctional complexes. J Cell Sci. 2018:jcs.206789. doi:10.1242/jcs.206789.
   PubMed Web of Science ®Google Scholar
• Stevenson BR, Anderson JM, Braun ID, Mooseker MS. Phosphorylation of the tight-junction protein ZO-1 in two strains of Madin-Darby canine kidney cells which differ in transepithelial resistance. Biochem J. 1989;263(2):597–599. doi:10.1042/bj2630597.
   PubMed Web of Science ®Google Scholar
• Tsai L-CL, Xie L, Dore K, Xie L, Del Rio JC, King CC, Martinez-Ariza G, Hulme C, Malinow R, Bourne PE, et al. Zeta inhibitory peptide disrupts electrostatic interactions that maintain atypical protein kinase C in its active conformation on the scaffold p62. J Biol Chem. 2015;290(36):21845–21856. doi:10.1074/jbc.M115.676221.
   PubMed Web of Science ®Google Scholar
• Laudanna C, Mochly-Rosen D, Constantin G, Butcher EC, Liron T. Evidence of ζ protein kinase C involvement in polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis. J Biol Chem. 1998;273(46):30306–30315. doi:10.1074/jbc.273.46.30306.
   PubMed Web of Science ®Google Scholar
• Steinberg SF. Structural basis of protein kinase C isoform function. Physiol Rev. 2008;88(4):1341–1378. doi:10.1152/physrev.00034.2007.
   PubMed Web of Science ®Google Scholar
• Wu-Zhang AX, Schramm CL, Nabavi S, Malinow R, Newton AC. Cellular pharmacology of protein kinase Mζ (PKMζ) contrasts with its in vitro profile. J Biol Chem. 2012;287(16):12879–12885. doi:10.1074/jbc.M112.357244.
   PubMed Web of Science ®Google Scholar
• Brunner J, Schvartz D, Hainard A, Gouiller A, Borchard G. Impact of L-R5 permeation enhancer on TJs opening cellular mechanisms. 2022. Unpublished Paper.
   Google Scholar
• Ragupathy S, Esmaeili F, Paschoud S, Sublet E, Citi S, Borchard G. Toll-like receptor 2 regulates the barrier function of human bronchial epithelial monolayers through atypical protein kinase C zeta, and an increase in expression of claudin-1. Tissue Barriers. 2014;2:e29166. doi:10.4161/tisb.29166.
   PubMedGoogle Scholar
• Ragupathy S, Brunner J, Borchard G. Short peptide sequence enhances epithelial permeability through interaction with protein kinase C. Eur J Pharm Sci. 2021;160:105747. doi:10.1016/j.ejps.2021.105747.
   PubMed Web of Science ®Google Scholar
• Guo C, Wang H, Liang W, Xu W, Li Y, Song L, Zhang D, Hu Y, Han B, Wang W, et al. Bilobalide reversibly modulates blood-brain barrier permeability through promoting adenosine A1 receptor-mediated phosphorylation of actin-binding proteins. Biochem Biophys Res Commun. 2020;526(4):1077–1084. doi:10.1016/j.bbrc.2020.03.186.
   PubMed Web of Science ®Google Scholar
• Song H, Zhang J, He W, Wang P, Wang F. Activation of cofilin increases intestinal permeability via depolymerization of F-Actin during hypoxia in vitro. Front Physiol. 2019;10:1455. doi:10.3389/fphys.2019.01455.
   PubMed Web of Science ®Google Scholar
• Maher M, Illum. Transmucosal absorption enhancers in the drug delivery field. Pharmaceutics. 2019;11(7):339. doi:10.3390/pharmaceutics11070339.
   PubMed Web of Science ®Google Scholar
• Welch J, Wallace J, Lansley AB, Roper C. Evaluation of the toxicity of sodium dodecyl sulphate (SDS) in the MucilAirTM human airway model in vitro. Regul Toxicol Pharmacol. 2021;125:105022. doi:10.1016/j.yrtph.2021.105022.
   PubMed Web of Science ®Google Scholar
• Guo H, Gu F, Li W, Zhang B, Niu R, Fu L, Zhang N, Ma Y. Reduction of protein kinase C ζ inhibits migration and invasion of human glioblastoma cells. J Neurochem. 2009;109(1):203–213. doi:10.1111/j.1471-4159.2009.05946.x.
   PubMed Web of Science ®Google Scholar
• Cheney KL, White A, Mudianta IW, Winters AE, Quezada M, Capon RJ, Mollo E, Garson MJ. Choose your weaponry: selective storage of a single toxic compound, latrunculin A, by closely related nudibranch molluscs. PLoS ONE. 2016;11(1):e0145134. doi:10.1371/journal.pone.0145134.
   PubMed Web of Science ®Google Scholar
• Marchant GE. Hormesis and toxic torts. Hum Exp Toxicol. 2008;27(2):97–107. doi:10.1177/0960327107086567.
   PubMedGoogle Scholar
• Maher S, Mrsny RJ, Brayden DJ. Intestinal permeation enhancers for oral peptide delivery. Adv Drug Deliv Rev. 2016;106(Pt B):277–319. doi:10.1016/j.addr.2016.06.005.
   PubMed Web of Science ®Google Scholar
• Maher S, Leonard TW, Jacobsen J, Brayden DJ. Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic. Adv Drug Deliv Rev. 2009;61(15):1427–1449. doi:10.1016/j.addr.2009.09.006.
   PubMed Web of Science ®Google Scholar
• Twarog C, Liu K, O’Brien PJ, Dawson KA, Fattal E, Illel B, Brayden DJ. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C10. Eur J Pharm Biopharm. 2020;152:95–107. doi:10.1016/j.ejpb.2020.04.023.
   PubMed Web of Science ®Google Scholar
• Raoof AA, Chiu P, Ramtoola Z, Cumming IK, Teng C, Weinbach SP, Hardee GE, Levin AA, Geary RS. Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate. J Pharm Sci. 2004;93(6):1431–1439. doi:10.1002/jps.20051.
   PubMed Web of Science ®Google Scholar
• Borrull A, López-Martínez G, Poblet M, Cordero-Otero R, Rozès N. New insights into the toxicity mechanism of octanoic and decanoic acids on Saccharomyces cerevisiae. Yeast. 2015;32(5):451–460. doi:10.1002/yea.3071.
   PubMed Web of Science ®Google Scholar
• Løvstad RA. Fatty acid induced hemolysis. protective action of ceruloplasmin, albumins, thiols and vitamin C. Int J Biochem. 1986;18(9):771–775. doi:10.1016/0020-711X(86)90052-2.
   PubMedGoogle Scholar
• Gradauer K, Dünnhaupt S, Vonach C, Szöllösi H, Pali-Schöll I, Mangge H, Jensen-Jarolim E, Bernkop-Schnürch A, Prassl R. Thiomer-coated liposomes harbor permeation enhancing and efflux pump inhibitory properties. J Control Release. 2013;165(3):207–215. doi:10.1016/j.jconrel.2012.12.001.
   PubMed Web of Science ®Google Scholar
• Hombach J, Bernkop-Schnürch A. Chitosan solutions and particles: evaluation of their permeation enhancing potential on MDCK cells used as blood brain barrier model. Int J Pharm. 2009;376(1–2):104–109. doi:10.1016/j.ijpharm.2009.04.027.
   PubMed Web of Science ®Google Scholar
• Ma H, O’Kennedy R. The structure of natural and recombinant antibodies. In: Houen G, editor. Peptide Antibodies. New York, New York, NY: Springer; 2015. p. 7–11. doi:10.1007/978-1-4939-2999-3_2.
   Google Scholar
• Jain S, Suzuki T, Seth A, Samak G, Rao R. Protein kinase Cζ phosphorylates occludin and promotes assembly of epithelial tight junctions. Biochem J. 2011;437(2):289–299. doi:10.1042/BJ20110587.
   PubMedGoogle Scholar
• Verdurmen WPR, Bovee-Geurts PH, Wadhwani P, Ulrich AS, Hällbrink M, van Kuppevelt TH, Brock R. Preferential uptake of L- versus D-Amino acid cell-penetrating peptides in a cell type-dependent manner. Chem Biol. 2011;18:1000–1010. doi:10.1016/j.chembiol.2011.06.006.
   PubMedGoogle Scholar